Online pharmacy bill passage protects legitimate sellers from illegal infringement
ALEXANDRIA, Va. The House of Representatives’ passage on Tuesday of H.R. 6353, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 won praise from the National Association of Chain Drug Stores.
“There is a growing number of Web sites that masquerade as legitimate pharmacies, luring consumers into schemes to obtain medications without a prescription or valid patient-prescriber relationship,” NACDS said in the statement. “These ‘rogue’ Web sites threaten the health and safety of consumers. H.R. 6353 would establish effective policies to curb these Web sites and to prevent them from selling controlled substances.”
“NACDS members operate legitimate, state-licensed pharmacies, many of which have an associated and branded Internet Web site that offers customers the convenience of contacting their pharmacy via the Internet for medication and healthcare needs,” the statement continued. “H.R. 6353 recognizes these legitimate operations and would not interfere with the important services and products that our members offer online.”
Bristol-Myers Squib ups off for ImClone buyout
NEW YORK Bristol-Myers Squibb announced Monday that it would increase its offer for ImClone after the biotech rejected a previous offer as too low.
Bristol had previously offered $60 a share for the company, but has increased its offer to $62 a share, or $4.7 billion. That’s still far below the $70 a share that ImClone chairman Carl Icahn has said an unnamed pharmaceutical company has offered.
ImClone and Bristol jointly market the cancer drug Erbitux (cetuximab), and Bristol owns 16.6 percent of ImClone’s stock.
Roche assures flu vaccines will be in stock for season
NUTLEY, N.J. Ample supplies of the flu drug Tamiflu will be available throughout the country during the flu season, manufacturer Roche said Tuesday.
The vaccine, known generically as oseltamivir phosphate, is approved for treating and preventing influenza in adults and children aged 1 and older.
The Centers for Disease Control and Prevention considers it an important second line of defense against the flu.
“We understand that pharmacists do their best to stock appropriate amounts of antiviral medications, such as Tamiflu, for use during the flu season,” Roche medical director Dominick Iacuzio said. “However, the incidence and severity of seasonal flu remains unpredictable from year to year, and some pharmacies may still be faced with greater-than-expected demand during the season.”